Prev Arrow Stocks

DuPont de Nemours Inc. ($DD) Stock Forecast: Up 8.5% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is DuPont de Nemours Inc.?

DuPont (DD) operates in various sectors such as healthcare, water filtration, and biofuel processing, following the DowDuPont merger in 2019.

Why is DuPont de Nemours Inc. going up?

DD stock is up 8.5% on May 5, 2026 16:56

  • DuPont (DD) showed strong bullish movement recently.
  • The company's positive market performance is linked to its robust financial results, surpassing Q1 2026 earnings estimates and increasing its annual profit projection.
  • Demand growth in healthcare and water filtration areas, along with supportive biofuel blending regulations, are key factors driving DuPont's positive prospects.
  • Investor confidence was bolstered by DuPont's announcement of a $275 million stock repurchase program, highlighting its commitment to enhancing shareholder value.

DD Price Chart

DD Technical Analysis

DD News

Grain trader ADM raises profit forecast on biofuel demand outlook

Grain trader Archer-Daniels-Midland (ADM) has raised its full-year profit forecast and exceeded quarterly earnings estimates, driven by a strong oilseed processing outlook and clarified U.S. biofuel blending mandates. The company now expects 2026 adjusted earnings per share between $4.15 and $4.70, up from its previous forecast. This optimism follows the U.S. administration's order for refiners to blend a record amount of biofuels, providing a stable regulatory framework for ADM's operations despite some challenges like a quarterly operating loss in its crushing unit.

https://www.reuters.com/sustainability/climate-energy/grain-trader-adm-raises-profit-forecast-biofuel-demand-outlook-2026-05-05/

0 Missing News Article Image Grain trader ADM raises profit forecast on biofuel demand outlook

DuPont Should Benefit From Long-Term Growing Demand for Healthcare and Water Filtration

DuPont, a specialty chemicals company, is expected to benefit from increasing long-term demand in the healthcare and water filtration sectors. The article, by Seth Goldstein, highlights DuPont's evolving portfolio and its history, noting its formation from the 2019 DowDuPont merger and subsequent separations. This analysis suggests a positive outlook for the company's future performance.

https://www.morningstar.com/company-reports/1479624-dupont-should-benefit-from-long-term-growing-demand-for-healthcare-and-water-filtration

1 News Article Image DuPont Should Benefit From Long-Term Growing Demand for Healthcare and Water Filtration

Transcript: DuPont de Nemours Q1 2026 Earnings Conference Call

DuPont de Nemours exceeded its Q1 2026 guidance with 2% organic sales growth, 130 basis points of margin expansion, and double-digit adjusted EPS growth. The company raised its full-year 2026 financial guidance and announced a $275 million accelerated share repurchase as part of its capital allocation strategy. DuPont also completed the divestiture of the aramids business and issued its 2026 sustainability report, highlighting new 2035 sustainability goals, with management expressing confidence in navigating macro and geopolitical challenges.

https://www.benzinga.com/insights/news/26/05/52280717/transcript-dupont-de-nemours-q1-2026-earnings-conference-call

2 News Article Image Transcript: DuPont de Nemours Q1 2026 Earnings Conference Call

Earnings Flash (DD) DuPont de Nemours Posts Q1 Net Sales $1.68B, vs. FactSet Est of $1.67B

DuPont de Nemours (DD) announced its first-quarter net sales reached $1.68 billion, surpassing FactSet's estimate of $1.67 billion. The company also reported Q1 Adjusted EPS of $0.55, higher than FactSet's expectation of $0.48, and raised its 2026 annual profit and sales forecasts. This financial performance indicates stronger-than-expected results for the chemical manufacturer.

https://www.marketscreener.com/news/earnings-flash-dd-dupont-de-nemours-posts-q1-net-sales-1-68b-vs-factset-est-of-1-67b-ce7f58dfd08ff02c

3 News Article Image Earnings Flash (DD) DuPont de Nemours Posts Q1 Net Sales $1.68B, vs. FactSet Est of $1.67B

DuPont Lifts Outlook, Plans $275 Million Buyback

DuPont de Nemours increased its full-year earnings and sales outlook and announced a $275 million stock buyback program after reporting a profit in the first quarter. The company now anticipates full-year adjusted earnings between $2.35 and $2.40 per share and net sales between $7.16 billion and $7.22 billion. This improved forecast reflects a positive shift from previous estimates.

https://www.wsj.com/business/earnings/dupont-lifts-outlook-plans-275-million-buyback-0551c317

4 Missing News Article Image DuPont Lifts Outlook, Plans $275 Million Buyback

DuPont de Nemours Inc. Price History

05.00.2026 - DD Stock was up 1.2%

  • DuPont's stock has been testing investor patience due to a sideways grind, leading to a cautious outlook.
  • On the other hand, Dow Inc. has been quietly making waves in the market with its strategic pivot towards advanced materials for tech megatrends, positioning itself as a foundational technology supplier.
  • The bullish movement in DuPont's stock today could be attributed to potential positive developments in its specialty materials segment or a shift in investor sentiment towards the company's future prospects.
  • Meanwhile, Dow Inc.'s strong performance might be fueled by its focus on higher-margin, sustainable products aligned with modern technologies, attracting investors looking for stability and long-term growth opportunities.

04.01.2026 - DD Stock was up 5.2%

  • DuPont's recent positive performance is linked to the release of the FilmTec™ MXP RO-8038-FF element, designed to enhance productivity and efficiency for dairy processors, potentially driving up demand for the company's offerings.
  • The development of innovative solutions in the dairy reverse osmosis sector highlights DuPont's dedication to delivering advanced products across industries, underscoring its adaptability to changing market dynamics.
  • Investor confidence seems to have been boosted by DuPont's strategic focus on higher-margin sectors such as electronics and advanced materials, indicating prospects for future growth and profitability.
  • The launch of the Liveo™ C6-8XX Liquid Silicone Rubber series for healthcare applications showcases DuPont's commitment to diversification and innovation, reinforcing investor trust in the company's long-term outlook.

08.03.2026 - DD Stock was up 5.0%

  • The bullish movement in DuPont's stock (DD) could be attributed to the company's recent launch of innovative ultrafiltration modules with integrated pre-filters, showcasing its commitment to sustainability and efficiency in water treatment solutions.
  • The ongoing lawsuit against Chemours over PFAS contamination may have also positively impacted DuPont's stock, as the company's efforts to address environmental concerns and improve filtration technologies align with growing ESG (Environmental, Social, and Governance) considerations among investors.
  • The positive outlook for the United States Silica Aerogel Market, with key players like Cabot Corporation (a competitor of DuPont) driving market growth, could have contributed to overall optimism in the materials science sector, benefiting DuPont's stock performance.
  • Ecolab's strong financial performance and investor confidence, despite potential valuation risks, may have influenced market sentiment positively, reflecting broader market trends that could have lifted DuPont's stock along with other industry peers.

05.10.2025 - DD Stock was up 6.4%

  • DuPont de Nemours (DD) is expected to surpass Wall Street estimates for key metrics and report positive Q3 earnings.
  • The high expectations for strong performance in key metrics likely boosted investor confidence, contributing to the stock's bullish movement.
  • Investor sentiment is positive regarding DuPont de Nemours' growth potential and profitability, propelling the stock price upwards.
  • The market's favorable response to the upcoming earnings report signals an optimistic outlook for DuPont de Nemours in the near term.

11.01.2026 - DD Stock was up 5.1%

  • The company reported strong Q4 2025 earnings, surpassing guidance and demonstrating growth in organic sales and operating EBITDA, possibly influencing the bullish movement.
  • Analysts have given varied but largely positive ratings for DD, with KeyBanc raising its price target, showing confidence in the company's future performance.
  • The projected growth in the Flame Resistant Clothing Market, an industry where DuPont de Nemours is a major player, may have also positively affected investor sentiment.
  • The company's strategic executive team expansion and successful operational changes further reinforce the market's optimistic view on DuPont de Nemours.

06.02.2026 - DD Stock was down 7.6%

  • Today's bearish movement in DuPont's stock (NYSE: DD) could be due to profit-taking by investors following a recent uptrend, with no significant negative developments directly affecting the company.
  • Upgrades to DuPont's WAVE PRO water treatment modeling tool, incorporating RO and NF technologies, may suggest long-term growth prospects, though short-term market effects could be at play.
  • The addition of James C. Collins, Jr., former CEO of Corteva Agriscience, to AGCO Corporation's board of directors may have indirectly influenced DuPont's stock, showcasing strong leadership in the agriculture sector and potentially diverting investor focus.
  • Growing sectors like soy derivatives and nose wire for face masks have garnered market attention, possibly leading investors to temporarily shift away from DuPont and contributing to its bearish movement.

10.01.2026 - DD Stock was up 5.2%

  • DuPont de Nemours ($DD) stock experienced a strong bullish movement following the release of its Q4 2025 earnings, despite missing revenue expectations. This could be attributed to several factors:
  • The earnings report beating analyst estimates for earnings per share ($0.46 per share) might have instilled confidence in investors regarding the company's profitability and financial performance.
  • The positive outlook for 2026, with forecasts of strong net sales and adjusted profit driven by healthcare gains and restructuring efforts, likely contributed to the bullish sentiment surrounding the stock.
  • Strategic initiatives such as the sale of its Aramids business and the planned separation of its electronics unit are viewed favorably by investors as they signal a focus on core competencies and potential for future growth.
  • Overall, the combination of better-than-expected earnings, positive forecasts, and strategic restructuring efforts has likely fueled investor optimism and propelled DuPont de Nemours ($DD) stock to a bullish trajectory.

10.02.2026 - DD Stock was up 5.6%

  • The rise in the stock price of DuPont (DD) today may be linked to the following factors:
  • Strong Q4 earnings surpassing analyst forecasts, along with the announcement of a quarterly dividend, indicating robust financial results and investor confidence.
  • A collective "Moderate Buy" rating from various research entities and an uptick in institutional investors' ownership could have influenced overall market sentiment.
  • Despite legal disputes like the PFAS chemicals lawsuit, DuPont's proactive stance on environmental issues and sustained competitive edge in sectors like Heat Seal Coating and Body Protection Equipment might have bolstered the bullish trajectory.
  • Collaborative efforts with industry leaders such as 3M and Dow Inc., particularly in segments like Heat Seal Coating, could have also positively shaped investors' perspectives on DuPont's growth potential.

10.02.2026 - DD Stock was up 5.6%

  • DuPont (DD) stock showed significant upward momentum recently.
  • Kevin Meyers and Howard Ungerleider have joined the board amidst discussions with activist investor Elliott Investment Management LP, suggesting a leadership shift to address the company's performance.
  • DuPont's Q4 earnings exceeded analyst expectations, and the announcement of a quarterly dividend has bolstered investor confidence.
  • Despite ongoing legal issues, such as a lawsuit regarding PFAS chemicals, DuPont's strategic decisions and financial results seem to have outweighed these concerns, driving the recent market gains.

05.04.2026 - DD Stock was up 5.3%

  • Exceeded Q1 2026 expectations with organic sales growth, improved margins, and double-digit adjusted EPS growth, resulting in a positive market response.
  • Solid financial performance, including exceeding net sales projections and raising annual profit and sales forecasts, bolstered investor confidence and drove up the stock price.
  • Strategic initiatives like the accelerated share repurchase program and enhanced outlook demonstrate management's belief in the company's ability to overcome challenges and achieve sustainable growth, enhancing investor confidence.

05.04.2026 - DD Stock was up 8.5%

  • DuPont (DD) showed strong bullish movement recently.
  • The company's positive market performance is linked to its robust financial results, surpassing Q1 2026 earnings estimates and increasing its annual profit projection.
  • Demand growth in healthcare and water filtration areas, along with supportive biofuel blending regulations, are key factors driving DuPont's positive prospects.
  • Investor confidence was bolstered by DuPont's announcement of a $275 million stock repurchase program, highlighting its commitment to enhancing shareholder value.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.